The Advisory Committee is an esteemed group of industry thought leaders assembled by BIO to shape this event’s conference program by collaboratively identifying topics and speakers that will facilitate engaging and informative discussions.
Jennifer Hawks Bland
Chief Executive Officer
NewYorkBIO
Janice Bourque
Managing Director, Life Sciences
Hercules Technology Growth Capital
Aoife Brennan, MB, CHB
President and CEO
Synlogic
Noël Brown
Managing Director
Cantor Fitzgerald
Vered Caplan
CEO and Director
Orgenesis Inc.
Jie D'Elia, PhD
Vice President, Business Development, Hematology, Cell Therapy, and Translational Medicine
Bristol-Myers Squibb
Peter Fong, PhD
Senior Managing Director, Head of Company Creation
RTW investments
Andrew Gitkin
Managing Director, Co-Head of Healthcare Investment Banking
Raymond James
Lan Huang, PhD
Co-founder, Chairman & Chief Executive Officer
BeyondSpring
Anna Kazanchyan, MD
Founder & CEO
Saghmos Therapeutics
Ciara Kennedy, PhD
President and CEO
Amplyx
Jonathan Leff
Partner, Deerfield Management
Chairman, Deerfield Institute
Lucy Lu, MD
President and CEO
Avenue Therapeutics
Bibhash Mukhopadhyay, PhD
Principal
New Enterprise Associates
Sara Nayeem, MD
Partner
New Enterprise Associates
Kimberly Nearing
Venture Partner, BVCF Management, Ltd.
Board of Directors, BayHelix
Kuldeep Neote, PhD
Vice President External Innovation
Eli Lilly and Company
Susan Peschin, MHS
President and Chief Executive Officer
Alliance for Aging Research
Dennis J. Purcell
Founder and Senior Advisor
Aisling Capital
Yasmeen Rahimi, PhD
Managing Director & Senior Research Analyst, Co-Head of Biotechnology Research
ROTH Capital Partners
Stephen Ritoch
Chairman & Chief Executive Officer
Blaise Group International
Philip Ross
Vice Chairman, Healthcare Investment Banking
J.P. Morgan
Mahendra Shah, PhD
Managing Director
Vivo Capital
Jennifer Sheng
Managing Director, Healthcare Equity Capital Markets
Citigroup Global Markets
Marco Taglietti, MD
President and CEO
SCYNEXIS
BIO DOUBLE HELIX SPONSORS
BIO HELIX SPONSORS
